Hormone therapy, C-reactive protein, and progression of atherosclerosis: Data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 907-911

  Lakoski, Susan G ^a   Brosnihan, Bridget ^a   Herrington, David M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; INTERLEUKIN 6; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; PROGESTINS;

EID: 27744479181     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.11.025     Document Type: Article

References (25)

1. D. Grady, S.M. Rubin, and D.B. Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
2. M. Cushman, C. Legault, and E. Barrett-Connor Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study Circulation 100 1999 717 722
3. P.M. Ridker, C.H. Hennekens, and J.E. Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
4. A.D. Pradhan, J.E. Manson, and J.E. Rossouw Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987
5. J.V. Castell, M.J. Gomez-Lechon, and M. David Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes FEBS Lett 242 1989 237 239
6. D.M. Herrington, D.R. Reboussin, and K.P. Klein The Estrogen Replacement and Atherosclerosis (ERA) Study: study design and baseline characteristics of the cohort Control Clin Trials 21 2000 257 285
7. D.M. Herrington, D.R. Reboussin, and K.B. Brosnihan Effects of estrogen replacement on the progression of coronary-artery atherosclerosis N Engl J Med 343 2000 522 529
8. W.H. Leung, W. Sanders, and E.L. Alderman Coronary artery quantitation and data management system for paired angiograms Catheter Cardiovasc Diagn 24 1991 121 134
9. M.D. Luyer, S. Khosla, and W.G. Owen Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women J Clin Endocrinol Metab 86 2001 3629 3634
10. S. Lamon-Fava, B. Posfai, and E.J. Schaefer Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women Am J Cardiol 91 2003 252 254
11. A. Silvestri, O. Gebara, and C. Vitale Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response Circulation 107 2003 3165 3169
12. P.J. Manning, W.H. Sutherland, and A.R. Allum Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with type 2 diabetes Diabet Med 19 2002 847 852
13. W.M. van Baal, P. Kenemans, and M.J. van der Mooren Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women Thromb Haemost 81 1999 925 928
14. K.M. Prestwood, C. Unson, and M. Kulldorff The effect of different doses of micronized 17β-estradiol on C-reactive protein, interleukin-6, and lipids in older women J Gerontol A Biol Sci Med Sci 59 2004 827 832
15. S.O. Skouby, J. Gram, and L.F. Andersen Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations Am J Obstet Gynecol 186 2002 969 977
16. S. Stork, C. von Schacky, and P. Angerer The effect of 17β-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial Atherosclerosis 165 2002 301 307
17. E.A. Bermudez, N. Rifai, and J. Buring Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women Arterioscler Thromb Vasc Biol 22 2002 1668 1673
18. A. Wakatsuki, Y. Okatani, and N. Ikenoue Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen Circulation 105 2002 1436 1439
19. T.J. Wang, B.H. Nam, and P.W. Wilson Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study Arterioscler Thromb Vasc Biol 22 2002 1662 1667
20. I.M. Van Der Meer, M.P. De Maat, and A.E. Hak C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study Stroke 33 2002 2750 2755
21. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
22. V. Pasceri, J.S. Cheng, and J.T. Willerson Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534
23. S.K. Venugopal, S. Devaraj, and I. Yuhanna Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
24. S.K. Venugopal, S. Devaraj, and I. Jialal C-reactive protein decreases prostacyclin release from human aortic endothelial cells Circulation 108 2003 1676 1678
25. A. Nakagomi, S.B. Freedman, and C.L. Geczy Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment Circulation 101 2000 1785 1791